3 Smartest Dividend Stocks to Buy Now
When the market entered a correction in February and March,…
Buy
59
AJG Quote, Financials, Valuation and Earnings
Last price:
$344.61
Seasonality move
:
2.53%
Day range:
$341.00 - $346.95
52-week range:
$230.08 - $346.95
Dividend yield:
0.71%
P/E ratio:
52.95x
P/S ratio:
6.72x
P/B ratio:
4.36x
Volume:
1.8M
Avg. volume:
1.5M
1-year change:
38.07%
Market cap:
$87.9B
Revenue:
$11.6B
EPS (TTM):
$6.52
Analysts' Opinion
-
Consensus RatingArthur J. Gallagher & has received a consensus rating of Hold. The company's average rating is a Hold based on 6 Buy ratings, 8 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $329.47, Arthur J. Gallagher & has an estimated downside of -4.57% from its current price of $345.24.
-
Price Target UpsideAccording to analysts, the highest upside price target is $388.00 representing -100% upside increase from its current price of $345.24.
Fair Value
-
According to the consensus of 14 analysts, Arthur J. Gallagher & has -4.57% downside to fair value with a price target of $329.47 per share.
AJG vs. S&P 500
-
Over the past 5 trading days, Arthur J. Gallagher & has overperformed the S&P 500 by 4.07% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Arthur J. Gallagher & does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Arthur J. Gallagher & has grown year-over-year revenues for 9 quarters straight. In the most recent quarter Arthur J. Gallagher & reported revenues of $2.7B.
Earnings Growth
-
Arthur J. Gallagher & has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Arthur J. Gallagher & reported earnings per share of $1.12.
Enterprise value:
86.1B
EV / Invested capital:
--
Price / LTM sales:
6.72x
EV / EBIT:
38.22x
EV / Revenue:
7.45x
PEG ratio (5yr expected):
1.13x
EV / Free cash flow:
35.28x
Price / Operating cash flow:
31.83x
Enterprise value / EBITDA:
27.82x
Gross Profit (TTM):
$4.9B
Return On Assets:
2.46%
Net Income Margin (TTM):
12.66%
Return On Equity:
11.06%
Return On Invested Capital:
6.53%
Operating Margin:
17.44%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $8.6B | $10.1B | $11.6B | $2.4B | $2.7B | |
| Gross Profit | $3.6B | $4.2B | $4.9B | $964.9M | $1.1B | |
| Operating Income | $1.7B | $1.9B | $2.3B | $324.6M | $473.7M | |
| EBITDA | $2.2B | $2.1B | $3.1B | $137M | $660.7M | |
| Diluted EPS | $5.20 | $4.44 | $6.52 | -$0.15 | $1.12 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $11.1B | $17.7B | $22.3B | $32.1B | $44.1B | |
| Total Assets | $22.3B | $33.3B | $38.4B | $51.6B | $64.3B | |
| Current Liabilities | $10.1B | $16.7B | $21.3B | $31.1B | $29.3B | |
| Total Liabilities | $16.1B | $24.8B | $29.2B | $40.8B | $44.1B | |
| Total Equity | $6.2B | $8.6B | $9.2B | $10.8B | $20.2B | |
| Total Debt | $4.5B | $6.3B | $6.1B | $8B | $13.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.4B | $2B | $2.6B | $693.6M | $739.3M | |
| Cash From Investing | -$1B | -$3.3B | -$1.6B | -$1.9B | -$857.4M | |
| Cash From Financing | $212.6M | $2.9B | $13.1B | $982.1M | $12.5B | |
| Free Cash Flow | $1.2B | $1.8B | $2.4B | $647.6M | $695.7M | |
AJG
Sector
Market Cap
$87.9B
$614.3M
Price % of 52-Week High
99.51%
85.46%
Dividend Yield
0.71%
1.98%
Shareholder Yield
-12.95%
3.73%
1-Year Price Total Return
38.07%
7.6%
Beta (5-Year)
0.641
0.558
Dividend yield:
0.71%
Annualized payout:
$2.40
Payout ratio:
35.92%
Growth streak:
14 years
Technicals
8-day SMA
Buy
Level
$338.12
200-day SMA
Buy
Level
$292.89
Bollinger Bands (100)
Buy
Level
285.56 - 326.26
Chaikin Money Flow
Buy
Level
286.3M
20-day SMA
Buy
Level
$333.65
Relative Strength Index (RSI14)
Buy
Level
66.77
ADX Line
Buy
Level
28.59
Williams %R
Sell
Level
-6.5068
50-day SMA
Buy
Level
$320.84
MACD (12, 26)
Buy
Level
5.30
25-day Aroon Oscillator
Buy
Level
60
On Balance Volume
Neutral
Level
354.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.6477)
Sell
CA Score
(Annual)
Level (-1.282)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-0.5384)
Buy
Piotroski F Score
(Annual)
Level (8)
Sell
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Founded in 1927 as a one-person agency, Gallagher’s primary business is insurance brokerage, with a focus on serving middle-market companies. The company’s risk management segment provides third-party claims adjustment to companies that choose to self-insure. Gallagher has about 56,000 employees and generates about a third of its revenue internationally, primarily in Australia, Canada, New Zealand, and the UK.
Stock Forecast FAQ
In the current month, AJG has received 6 Buy ratings 8 Hold ratings, and 0 Sell ratings. The AJG average analyst price target in the past 3 months is $329.47.
-
Where Will Arthur J. Gallagher & Stock Be In 1 Year?
According to analysts, the consensus estimate is that Arthur J. Gallagher & share price will drop to $329.47 per share over the next 12 months.
-
What Do Analysts Say About Arthur J. Gallagher &?
Analysts are divided on their view about Arthur J. Gallagher & share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Arthur J. Gallagher & is a Sell and believe this share price will rise from its current level to $267.00.
-
What Is Arthur J. Gallagher &'s Price Target?
The price target for Arthur J. Gallagher & over the next 1-year time period is forecast to be $329.47 according to 14 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 8 analysts rate the stock a Hold.
-
Is AJG A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Arthur J. Gallagher & is a Hold. 8 of 14 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of AJG?
You can purchase shares of Arthur J. Gallagher & via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Arthur J. Gallagher & shares.
-
What Is The Arthur J. Gallagher & Share Price Today?
Arthur J. Gallagher & was last trading at $344.61 per share. This represents the most recent stock quote for Arthur J. Gallagher &. Yesterday, Arthur J. Gallagher & closed at $345.24 per share.
-
How To Buy Arthur J. Gallagher & Stock Online?
In order to purchase Arthur J. Gallagher & stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is down 16.21% over the past day.
Sell
16
PCVX alert for Apr 1
Vaxcyte [PCVX] is down 2.91% over the past day.
Sell
47
RGC alert for Apr 1
Regencell Bioscience Holdings [RGC] is down 3.23% over the past day.
